Dear Doctor
This newsletter highlights some of Biosensis' well characterized antibodies against proteins involved in neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.
When you want the best reagents, trust Biosensis
The staff at Biosensis have over 60 years of combined experience in manufacturing and working with antibodies and have over 340 peer reviewed research publications in the field of neuroscience. We guarantee to provide you with the antibody information you need to get your research published. Recently, our anti-Parkin antibody ( R-114-100) was used by Song et al (2010) to identify immunohistochemical expression of Parkin in astrocytes from various parkinsonian syndromes. |